Tinnitus and Dementia: Two Real-World Evidence Studies Published

The analysis of data from everyday practice (“real-world data”) is playing an increasingly important role in science. They can provide findings (“real-world evidence”) that can hardly be generated in strictly regulated clinical trials, for example in large patient populations or on long-term use. 

The method also offers the possibility of researching interesting aspects of the use of already approved products without having to carry out a very complex and expensive trial. 

Schwabe is therefore increasingly using this type of scientific studies. 

Last year an evaluation of tinnitus treatments was published (Frontiers | Ginkgo biloba extract prescriptions are associated with less frequent repeat visits to ENT doctors due to tinnitus: a retrospective cohort study). It shows that the number of follow-up consultations was lower after patients received prescriptions of Ginkgo medicinal products as compared to other active ingredients. 

Another study with an observation period of up to 10 years shows that the progression of dementia severity was slower in patients receiving Ginkgo extract prescriptions (Ginkgo biloba Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data).

The publications are freely available on the Internet.

More news